MedTech Europe launches social media campaign on medical tests at risk of shortage
Posted on 09.09.2021
During the week of 30 August 2021, MedTech Europe launched a social media campaign of the recently published case studies that showcase four examples of medical tests that risk being in severe shortage after In vitro Diagnostics Regulation (IVDR) enters into full application on 26 May 2022.
These case studies shine a light on medical tests that help detect and prevent cancer, COVID-19, strokes, and diabetes. These tests may face severe shortage in less than a year because the revamped regulatory infrastructure that the IVDR will bring about is not ready yet and is expected not be by the time the new Regulation enters into full application.
MedTech Europe continues to advocate for rapid and sustainable solutions to prevent critical medical tests from being unavailable to patients.